EUCTR2005-000004-13-IT进行中（未招募）不适用
EVALUATION OF ACETYL -L-CARNITINE ST 200 TO REDUCE INTENSITY OF TAXANES- OR PLATINUM-INDUCED SENSORY NEUROPATHY
SIGMA-TA0 个研究点目标入组 172 人开始时间: 2006年3月14日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 172
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
EVALUATION OF ACETYL -L-CARNITINE (ST 200) TO REDUCE INTENSITY OF TAXANES- OR PLATINUM-INDUCED SENSORY NEUROPATHYPeripheral neurophaty in cancer patients previously treated with taxanes- or platinum-based chemotherapyMedDRA version: 7.0Level: HLGTClassification code 10027655EUCTR2005-000004-13-BESigma-Tau i.f.r. S.p.A.172
已完成
不适用
Evaluation of Acetyl-L-Carnitine (ST 200) to reduce intensity of taxanes- or platinum-induced sensory neuropathyTaxanes- or platinum-induced neuropathyNervous System DiseasesISRCTN85659215Sigma-Tau (Italy)172
进行中（未招募）
不适用
Phase II Explorative Study of Acetyl-L-Carnitine (ST 200) for Vincristine-Induced Neurotoxicity in Patients With Acute Lymphoblastic Leukemia (ALL).Treatment of peripheral sensitive neuropathy vinca alkaloid chemotherapy -induced.MedDRA version: 6.1Level: PTClassification code 10000846EUCTR2005-001508-38-ITSIGMA-TA
已完成
3 期
Acetyle Systeine and Contrast nephropathyephropathy due to contrast agents.Postprocedural renal failureIRCT201205305113N3ephrology Research Center, Tehran University of Medical Sciences549
已完成
不适用
Evaluation of the effect of L-carnitine administration on peritoneal membrane function in peritoneal dialysis patients.Secondary carnitine deficiencyJPRN-UMIN000031514Division of Nephrology, Department on Medicine, Kurume University60